Cell type-specific regulation of CCN2 protein expression by PI3K-AKT-FoxO signaling

Jana Samarin1, Iwona Cicha, Margarete Goppelt-Struebe

  • 1Department of Nephrology and Hypertension, Medical Clinic 4, University of Erlangen-Nürnberg, University Hospital Erlangen, 91054, Erlangen, Germany.

Insights

Connective tissue growth factor (CTGF, CCN2) regulation varies by cell type. In endothelial cells, PI3K-AKT signaling inversely affects CCN2 expression, with FoxO transcription factors acting as key activators.

Area of Science:

  • Cellular and Molecular Biology
  • Biochemistry
  • Physiology

Background:

  • Connective tissue growth factor (CTGF, CCN2) biological activity is modulated by intracellular signaling and extracellular interactions.
  • The phosphatidylinositol-3 kinase (PI3K)-AKT signaling pathway plays a critical role in regulating gene expression, including that of CCN2.
  • Cell type-specific differences in CCN2 regulation by PI3K-AKT signaling are increasingly recognized.

Purpose of the Study:

  • To investigate the cell type-dependent regulation of CCN2 expression by the PI3K-AKT signaling pathway.
  • To elucidate the role of FoxO transcription factors in mediating CCN2 gene expression in endothelial cells.
  • To understand the interplay between PI3K-AKT signaling, FoxO factors, and CCN2 regulation under varying shear stress conditions.

Main Methods:

  • Analysis of CCN2 expression in various cell types (smooth muscle cells, fibroblasts, epithelial cells, microvascular endothelial cells, HUVEC) under different PI3K-AKT signaling modulations.
  • In vitro flow-through system using HUVEC exposed to laminar flow.
  • Assessment of FoxO transcription factor localization (nuclear vs. cytoplasmic) and its correlation with CCN2 synthesis.

Main Results:

  • PI3K-AKT signaling exhibits cell type-dependent effects on CCN2 expression.
  • In endothelial cells, PI3K-AKT activation is inversely correlated with CCN2 expression, while inhibition upregulates CCN2.
  • FoxO transcription factors, negatively regulated by AKT, were identified as potent activators of CCN2 gene expression in endothelial cells, with enhanced nuclear localization correlating with increased CCN2 synthesis under non-uniform shear stress.

Conclusions:

  • FoxO transcription factors are key regulators of CCN2 gene expression, particularly in endothelial cells.
  • The PI3K-AKT pathway's effect on CCN2 expression is significantly influenced by the cellular context and the activity of FoxO transcription factors.
  • Understanding these regulatory mechanisms is crucial for deciphering CCN2's role in endothelial cell function and response to mechanical stimuli.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...